Evidence map›Paper›PMID 37231089›Full record

ArticleNature microbiology2023

Particular genomic and virulence traits associated with preterm infant-derived toxigenic Clostridium perfringens strains.

Raymond Kiu, Alexander G Shaw, Kathleen Sim, Antia Acuna-Gonzalez, Christopher A Price, Harley Bedwell, Sally A Dreger, Wesley J Fowler, Emma Cornwell, Derek Pickard and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genomic and clinical determinants of extraintestinalmedRxiv : the preprint server for health sciences · 2026
    Article
  9. Article
  10. Article
  11. Type A and DFrontiers in cellular and infection microbiology · 2026
    Article
  12. Review
  13. Comprehensive analysis ofGut microbes · 2025
    Article
  14. Review
  15. Gut microbes · 2025
    Article
  16. Article
  17. A Framework for Evaluation of New Processing Technologies in Human Milk Banking.Comprehensive reviews in food science and food safety · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 1 country.

Raymond KiuGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.ORCID 0000-0002-4483-1215
Alexander G ShawFaculty of Medicine, Imperial College London, London, UK.
Kathleen SimFaculty of Medicine, Imperial College London, London, UK.
Antia Acuna-GonzalezGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.ORCID 0000-0002-8062-925X
Christopher A PriceGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.ORCID 0000-0003-3161-1704
Harley BedwellGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.
Sally A DregerGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.ORCID 0000-0001-7104-6776
Wesley J FowlerGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.
Emma CornwellFaculty of Medicine, Imperial College London, London, UK.
Derek PickardDepartment of Medicine, University of Cambridge, Cambridge, UK.
Gusztav BeltekiNeonatal Intensive Care Unit, The Rosie Hospital, Cambridge, UK.
Jennifer MalsomGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.
Sarah PhillipsGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.
Gregory R YoungHub for Biotechnology in the Built Environment, Northumbria University, Newcastle upon Tyne, UK.ORCID 0000-0001-5342-1421
Zoe SchofieldGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.
Cristina Alcon-GinerGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.
Janet E BerringtonTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Christopher J StewartTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-6033-338X
Gordon DouganDepartment of Medicine, University of Cambridge, Cambridge, UK.
Paul ClarkeNorfolk and Norwich University Hospital, Norwich, UK.ORCID 0000-0001-6203-7632
Gillian DouceInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-6654-7346
Stephen D RobinsonGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK.ORCID 0000-0002-6606-7588
J Simon KrollFaculty of Medicine, Imperial College London, London, UK.
Lindsay J HallGut Microbes and Health, Quadram Institute Bioscience, Norwich, UK. lindsay.hall@quadram.ac.uk.ORCID 0000-0001-8938-5709
Quadram Institute · GBImperial College London · GBUniversity of East Anglia · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GBNorthumbria University · GBRosie Hospital · GBUniversity of Glasgow · GB

Funding

Biotechnology and Biological Sciences Research Council BB/R012490/1Biotechnology and Biological Sciences Research Council BBS/E/F/00044409Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10355Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356Biotechnology and Biological Sciences Research Council BBS/E/F/00PR10356
6 · The paper itself

Abstract

Clostridium perfringens is an anaerobic toxin-producing bacterium associated with intestinal diseases, particularly in neonatal humans and animals. Infant gut microbiome studies have recently indicated a link between C. perfringens and the preterm infant disease necrotizing enterocolitis (NEC), with specific NEC cases associated with overabundant C. perfringens termed C. perfringens-associated NEC (CPA-NEC). In the present study, we carried out whole-genome sequencing of 272 C. perfringens isolates from 70 infants across 5 hospitals in the United Kingdom. In this retrospective analysis, we performed in-depth genomic analyses (virulence profiling, strain tracking and plasmid analysis) and experimentally characterized pathogenic traits of 31 strains, including 4 from CPA-NEC patients. We found that the gene encoding toxin perfringolysin O, pfoA, was largely deficient in a human-derived hypovirulent lineage, as well as certain colonization factors, in contrast to typical pfoA-encoding virulent lineages. We determined that infant-associated pfoA

Indexed as

Clostridium perfringensInfant, Newborn, DiseasesAnimalsGenomicsHumansInfantInfant, NewbornInfant, PrematureMiceRetrospective StudiesVirulence

Identifiers

PMID37231089
PMCPMC10234813
OpenAlexW4378212666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.